{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 444347219
| IUPAC_name = 1-(5-Nitro-1,3-thiazol-2-yl)imidazolidin-2-one
| image = Niridazole.svg

<!--Clinical data-->
| tradename =
| MedlinePlus = a682128
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B / C / D / X -->
| pregnancy_category =
| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled-->
| legal_CA = <!-- Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL, P, POM, CD, or Class A, B, C -->
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->
| legal_status =
| routes_of_administration =

<!--Pharmacokinetic data-->
| bioavailability =
| protein_bound =
| metabolism =
| elimination_half-life =
| excretion =

<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 61-57-4
| ATC_prefix = P02
| ATC_suffix = BX02
| PubChem = 6093
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = N116U8Y5QQ
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D05170
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID = 5868

<!--Chemical data-->
| chemical_formula =
| C=6 | H=6 | N=4 | O=3 | S=1
| molecular_weight = 214.20 g/mol
| smiles = C1CN(C(=O)N1)C2=NC=C(S2)[N+](=O)[O-]
| StdInChI_Ref = {{stdinchicite|changed|chemspider}}
| StdInChI = 1S/C6H6N4O3S/c11-5-7-1-2-9(5)6-8-3-4(14-6)10(12)13/h3H,1-2H2,(H,7,11)
| StdInChIKey_Ref = {{stdinchicite|changed|chemspider}}
| StdInChIKey = RDXLYGJSWZYTFJ-UHFFFAOYSA-N
}}

'''Niridazole''' is a [[schistosomicide]].<ref>{{Cite journal 
| pmid = 6193406 
| year = 1983 
| last1 = Tracy | first1 = J. W. 
| last2 = Catto 
| last3 = Webster Lt 
| title = Reductive metabolism of niridazole by adult Schistosoma mansoni. Correlation with covalent drug binding to parasite macromolecules 
| volume = 24 
| issue = 2 
| pages = 291–299 
| journal = Molecular Pharmacology | first2 = B. A. | first3 = L. T.
}}</ref> It is used to treat [[schistosomiasis]], the helmintic disease caused by certain flatworms ([[trematode]]s) from the genus ''[[Schistosoma]]'' (formerly ''Bilharzia''). It is also known by its trade name '''Ambilhar'''. It is usually given as tablets.

Niridazole has [[central nervous system]] toxicity and can cause dangerous side effects, such as [[hallucination]]s.<ref>[http://toxnet.nlm.nih.gov/cgi-bin/sis/search2/f?./temp/~pr3DeG:1 Toxicology Data Network – Niridazole]</ref> Also, it may cause allergic reactions in sensitive people. However, it is one of the most effective schistosomicide drugs.<ref>{{Cite journal
| pmid = 1107578
| year = 1975
| author1 = Katz
| first1 = N
| title = Clinical evaluation of niridazole and hycanthone in schistosomiasis mansoni endemic areas
| journal = Journal of Toxicology and Environmental Health
| volume = 1
| issue = 2
| pages = 203–9
| doi = 10.1080/15287397509529322
}}</ref>

It has recently also been investigated for use in the treatment of [[periodontitis]].<ref>{{Cite journal
| last1 = Barat | first1 = R.
| last2 = Srinatha | first2 = A.
| last3 = Pandit | first3 = J.
| last4 = Mittal | first4 = N.
| last5 = Anupurba | first5 = S.
| title = Ethylcellulose inserts of an orphan drug for periodontitis: preparation, in vitro, and clinical studies
| journal = Drug delivery
| volume = 14
| issue = 8
| pages = 531–538
| year = 2007
| pmid = 18027183
| doi = 10.1080/10717540701606517
}}</ref><ref>{{Cite journal
| last1 = Barat | first1 = R.
| last2 = Srinatha | first2 = A.
| last3 = Pandit | first3 = J.
| last4 = Ridhurkar | first4 = D.
| last5 = Balasubramaniam | first5 = J.
| last6 = Mittal | first6 = N.
| last7 = Mishra | first7 = D.
| title = Niridazole biodegradable inserts for local long-term treatment of periodontitis: possible new life for an orphan drug
| journal = Drug delivery
| volume = 13
| issue = 5
| pages = 365–373
| year = 2006
| pmid = 16877312
| doi = 10.1080/10717540500398126
}}</ref>

== Mechanism of action ==
Niridazole is rapidly concentrated in the parasite and inhibits [[oogenesis]] and [[spermatogenesis]]. The compound also inhibits the [[phosphofructokinase]] [[enzyme]], leading to glycogen depletion and [[hepatic shift]].

== References ==
{{reflist}}

{{Anthelmintics}}

[[Category:Antiparasitic agents]]
[[Category:IARC Group 2B carcinogens]]
[[Category:Imidazolidinones]]
[[Category:Nitrothiazoles]]


{{Antiinfective-drug-stub}}